Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

ONO-5920/YM529 Confirmatory Study in Involutional Osteoporosis Patients

This study has been completed.
Ono Pharma USA Inc
Information provided by:
Astellas Pharma Inc Identifier:
First received: November 18, 2008
Last updated: July 8, 2010
Last verified: July 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2010
  Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)